Home > Insider Trading > Filing (0001179110-13-011149)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1434868	Esperion Therapeutics Inc.	ESPR	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1253886	G Patrick Enright	800 El Camino Real Suite 220 Menlo Park CA 94025		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-07-01	1,683,967	$0.00	1,683,967	No	4	C	Indirect	By Longitude Venture Partners, L.P.
Common Stock	Acquisiton	2013-07-01	33,753	$0.00	33,753	No	4	C	Indirect	By Longitude Capital Associates, L.P.
Common Stock	Acquisiton	2013-07-01	212,418	$14.00	1,896,385	No	4	P	Indirect	By Longitude Venture Partners, L.P.
Common Stock	Acquisiton	2013-07-01	4,258	$14.00	38,011	No	4	P	Indirect	By Longitude Capital Associates, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Longitude Venture Partners, L.P.
No	4	C	Indirect	By Longitude Capital Associates, L.P.
No	4	P	Indirect	By Longitude Venture Partners, L.P.
No	4	P	Indirect	By Longitude Capital Associates, L.P.

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2013-07-01	1,683,967	$0.00	1,683,967	$0.00
Common Stock	Series A Preferred Stock	Disposition	2013-07-01	33,753	$0.00	33,753	$0.00
Common Stock	Stock Option (right to buy)	Acquisiton	2013-07-01	21,471	$0.00	21,471	$14.00

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		No	4	C	Indirect
0		No	4	C	Indirect
21,471	2023-06-05	No	4	A	Direct

Footnotes

The Series A Preferred Stock was automatically converted into Common Stock on a 6.986-for-1 basis upon the closing of the Issuer's initial public offering without payment of further consideration and had no expiration date.
Mr. Enright is a managing member of Longitude Capital Partners, LLC ("Longitude Capital"). Longitude Capital, as general partner of each of Longitude Venture Partners, L.P. ("LVP") and Longitude Capital Associates, L.P. ("LCA"), has the power to vote and dispose of securities held by each of them and may be deemed to have beneficial ownership of the shares owned by LVP and LCA. Mr. Enright disclaims beneficial ownership of the shares held by the Longitude Capital entities, except to the extent of his pecuniary interest therein.
The option vests in equal monthly installments over a three-year period beginning from April 19, 2013.